HEADER TRANSFERASE 15-JUN-20 6XFI TITLE CRYSTAL STRUCTURES OF BETA-1,4-N-ACETYLGLUCOSAMINYLTRANSFERASE 2 TITLE 2 (POMGNT2): STRUCTURAL BASIS FOR INHERITED MUSCULAR DYSTROPHIES COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN O-LINKED-MANNOSE BETA-1,4-N- COMPND 3 ACETYLGLUCOSAMINYLTRANSFERASE 2; COMPND 4 CHAIN: A; COMPND 5 FRAGMENT: UNP RESIDUES 52-580; COMPND 6 SYNONYM: POMGNT2,EXTRACELLULAR O-LINKED N-ACETYLGLUCOSAMINE COMPND 7 TRANSFERASE-LIKE,GLYCOSYLTRANSFERASE-LIKE DOMAIN-CONTAINING PROTEIN COMPND 8 2; COMPND 9 EC: 2.4.1.312; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: POMGNT2, AGO61, C3ORF39, EOGTL, GTDC2; SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 7 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 9 EXPRESSION_SYSTEM_CELL_LINE: HEK293S KEYWDS MUSCULAR DYSTROPHY, ALPHA-DYSTROGLYCAN, O-MANNOSYLATION, POMGNT2, KEYWDS 2 TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR S.M.HALMO,J.YEH,L.WELLS,K.W.MOREMEN,W.N.LANZILOTTA REVDAT 1 21-APR-21 6XFI 0 JRNL AUTH J.Y.YANG,S.M.HALMO,J.PRAISSMAN,D.CHAPLA,D.SINGH,L.WELLS, JRNL AUTH 2 K.W.MOREMEN,W.N.LANZILOTTA JRNL TITL CRYSTAL STRUCTURES OF JRNL TITL 2 BETA-1,4-N-ACETYLGLUCOSAMINYLTRANSFERASE 2: STRUCTURAL BASIS JRNL TITL 3 FOR INHERITED MUSCULAR DYSTROPHIES. JRNL REF ACTA CRYSTALLOGR D STRUCT V. 77 486 2021 JRNL REF 2 BIOL JRNL REFN ISSN 2059-7983 JRNL PMID 33825709 JRNL DOI 10.1107/S2059798321001261 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.17.1_3660 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.00 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.330 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 47469 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.199 REMARK 3 R VALUE (WORKING SET) : 0.198 REMARK 3 FREE R VALUE : 0.227 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.070 REMARK 3 FREE R VALUE TEST SET COUNT : 1930 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 40.0000 - 4.8200 1.00 3503 149 0.1815 0.1915 REMARK 3 2 4.8200 - 3.8200 1.00 3334 141 0.1551 0.1837 REMARK 3 3 3.8200 - 3.3400 1.00 3293 140 0.1752 0.2105 REMARK 3 4 3.3400 - 3.0400 1.00 3280 138 0.2030 0.2209 REMARK 3 5 3.0400 - 2.8200 1.00 3251 138 0.2064 0.2203 REMARK 3 6 2.8200 - 2.6500 1.00 3254 137 0.2201 0.2605 REMARK 3 7 2.6500 - 2.5200 1.00 3230 138 0.2221 0.2514 REMARK 3 8 2.5200 - 2.4100 1.00 3226 136 0.2238 0.2978 REMARK 3 9 2.4100 - 2.3200 1.00 3208 137 0.2357 0.2579 REMARK 3 10 2.3200 - 2.2400 1.00 3233 136 0.2397 0.2919 REMARK 3 11 2.2400 - 2.1700 1.00 3209 136 0.2320 0.2827 REMARK 3 12 2.1700 - 2.1100 1.00 3199 136 0.2446 0.2597 REMARK 3 13 2.1100 - 2.0500 0.99 3161 134 0.2622 0.3477 REMARK 3 14 2.0500 - 2.0000 0.98 3158 134 0.2922 0.3724 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.260 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 23.740 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 40.10 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6XFI COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 16-JUN-20. REMARK 100 THE DEPOSITION ID IS D_1000249708. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 06-APR-19 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 49420 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.970 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 11.30 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 27.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.97 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.08 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: SAD REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 56.30 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.81 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M POTASSIUM/SODIUM TARTRATE, 0.1 M REMARK 280 BIS-TRIS, PH 7.5, 10% PEG10000, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 296K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 4 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -Y+1/2,X+1/2,Z REMARK 290 4555 Y+1/2,-X+1/2,Z REMARK 290 5555 -X+1/2,Y+1/2,-Z REMARK 290 6555 X+1/2,-Y+1/2,-Z REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 64.92000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 64.92000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 64.92000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 64.92000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 64.92000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 64.92000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 64.92000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 64.92000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 8560 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 43000 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -55.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 0.000000 -1.000000 0.000000 129.84000 REMARK 350 BIOMT2 2 -1.000000 0.000000 0.000000 129.84000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 HIS A 279 REMARK 465 THR A 280 REMARK 465 GLY A 281 REMARK 465 VAL A 282 REMARK 465 PRO A 283 REMARK 465 LEU A 284 REMARK 465 LYS A 466 REMARK 465 GLY A 467 REMARK 465 ARG A 468 REMARK 465 PRO A 469 REMARK 465 GLY A 470 REMARK 465 PRO A 471 REMARK 465 ARG A 472 REMARK 465 LYS A 473 REMARK 465 GLN A 474 REMARK 465 LYS A 475 REMARK 465 TRP A 476 REMARK 465 THR A 477 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 419 CG CD NE CZ NH1 NH2 REMARK 470 VAL A 465 CG1 CG2 REMARK 470 VAL A 478 CG1 CG2 REMARK 470 ARG A 518 CG CD NE CZ NH1 NH2 REMARK 470 ASN A 532 CG OD1 ND2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O GLU A 399 NE2 GLN A 491 1556 1.91 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 76 37.56 -146.15 REMARK 500 ASN A 126 -94.63 -129.36 REMARK 500 ASN A 160 87.85 -153.17 REMARK 500 ASP A 171 -58.10 -121.82 REMARK 500 GLU A 286 37.18 -162.91 REMARK 500 ASN A 302 52.59 -111.45 REMARK 500 TRP A 409 -32.81 -35.20 REMARK 500 LEU A 417 93.52 175.89 REMARK 500 ARG A 419 -108.37 -75.49 REMARK 500 VAL A 464 40.72 -89.42 REMARK 500 GLN A 529 105.34 -49.27 REMARK 500 GLU A 531 -160.32 -107.89 REMARK 500 ASN A 532 -159.59 -73.80 REMARK 500 VAL A 535 117.73 55.57 REMARK 500 THR A 547 -56.95 -120.38 REMARK 500 LYS A 566 -34.00 63.59 REMARK 500 REMARK 500 REMARK: NULL DBREF 6XFI A 52 580 UNP Q8NAT1 PMGT2_HUMAN 52 580 SEQRES 1 A 529 ASP TYR PRO LYS ALA LEU GLN ILE LEU MET GLU GLY GLY SEQRES 2 A 529 THR HIS MET VAL CYS THR GLY ARG THR HIS THR ASP ARG SEQRES 3 A 529 ILE CYS ARG PHE LYS TRP LEU CYS TYR SER ASN GLU ALA SEQRES 4 A 529 GLU GLU PHE ILE PHE PHE HIS GLY ASN THR SER VAL MET SEQRES 5 A 529 LEU PRO ASN LEU GLY SER ARG ARG PHE GLN PRO ALA LEU SEQRES 6 A 529 LEU ASP LEU SER THR VAL GLU ASP HIS ASN THR GLN TYR SEQRES 7 A 529 PHE ASN PHE VAL GLU LEU PRO ALA ALA ALA LEU ARG PHE SEQRES 8 A 529 MET PRO LYS PRO VAL PHE VAL PRO ASP VAL ALA LEU ILE SEQRES 9 A 529 ALA ASN ARG PHE ASN PRO ASP ASN LEU MET HIS VAL PHE SEQRES 10 A 529 HIS ASP ASP LEU LEU PRO LEU PHE TYR THR LEU ARG GLN SEQRES 11 A 529 PHE PRO GLY LEU ALA HIS GLU ALA ARG LEU PHE PHE MET SEQRES 12 A 529 GLU GLY TRP GLY GLU GLY ALA HIS PHE ASP LEU TYR LYS SEQRES 13 A 529 LEU LEU SER PRO LYS GLN PRO LEU LEU ARG ALA GLN LEU SEQRES 14 A 529 LYS THR LEU GLY ARG LEU LEU CYS PHE SER HIS ALA PHE SEQRES 15 A 529 VAL GLY LEU SER LYS ILE THR THR TRP TYR GLN TYR GLY SEQRES 16 A 529 PHE VAL GLN PRO GLN GLY PRO LYS ALA ASN ILE LEU VAL SEQRES 17 A 529 SER GLY ASN GLU ILE ARG GLN PHE ALA ARG PHE MET THR SEQRES 18 A 529 GLU LYS LEU ASN VAL SER HIS THR GLY VAL PRO LEU GLY SEQRES 19 A 529 GLU GLU TYR ILE LEU VAL PHE SER ARG THR GLN ASN ARG SEQRES 20 A 529 LEU ILE LEU ASN GLU ALA GLU LEU LEU LEU ALA LEU ALA SEQRES 21 A 529 GLN GLU PHE GLN MET LYS THR VAL THR VAL SER LEU GLU SEQRES 22 A 529 ASP HIS THR PHE ALA ASP VAL VAL ARG LEU VAL SER ASN SEQRES 23 A 529 ALA SER MET LEU VAL SER MET HIS GLY ALA GLN LEU VAL SEQRES 24 A 529 THR THR LEU PHE LEU PRO ARG GLY ALA THR VAL VAL GLU SEQRES 25 A 529 LEU PHE PRO TYR ALA VAL ASN PRO ASP HIS TYR THR PRO SEQRES 26 A 529 TYR LYS THR LEU ALA MET LEU PRO GLY MET ASP LEU GLN SEQRES 27 A 529 TYR VAL ALA TRP ARG ASN MET MET PRO GLU ASN THR VAL SEQRES 28 A 529 THR HIS PRO GLU ARG PRO TRP ASP GLN GLY GLY ILE THR SEQRES 29 A 529 HIS LEU ASP ARG ALA GLU GLN ALA ARG ILE LEU GLN SER SEQRES 30 A 529 ARG GLU VAL PRO ARG HIS LEU CYS CYS ARG ASN PRO GLU SEQRES 31 A 529 TRP LEU PHE ARG ILE TYR GLN ASP THR LYS VAL ASP ILE SEQRES 32 A 529 PRO SER LEU ILE GLN THR ILE ARG ARG VAL VAL LYS GLY SEQRES 33 A 529 ARG PRO GLY PRO ARG LYS GLN LYS TRP THR VAL GLY LEU SEQRES 34 A 529 TYR PRO GLY LYS VAL ARG GLU ALA ARG CYS GLN ALA SER SEQRES 35 A 529 VAL HIS GLY ALA SER GLU ALA ARG LEU THR VAL SER TRP SEQRES 36 A 529 GLN ILE PRO TRP ASN LEU LYS TYR LEU LYS VAL ARG GLU SEQRES 37 A 529 VAL LYS TYR GLU VAL TRP LEU GLN GLU GLN GLY GLU ASN SEQRES 38 A 529 THR TYR VAL PRO TYR ILE LEU ALA LEU GLN ASN HIS THR SEQRES 39 A 529 PHE THR GLU ASN ILE LYS PRO PHE THR THR TYR LEU VAL SEQRES 40 A 529 TRP VAL ARG CYS ILE PHE ASN LYS ILE LEU LEU GLY PRO SEQRES 41 A 529 PHE ALA ASP VAL LEU VAL CYS ASN THR HET UDP A 601 25 HET NAG A 602 14 HET PO4 A 603 5 HET PO4 A 604 5 HETNAM UDP URIDINE-5'-DIPHOSPHATE HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM PO4 PHOSPHATE ION HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 2 UDP C9 H14 N2 O12 P2 FORMUL 3 NAG C8 H15 N O6 FORMUL 4 PO4 2(O4 P 3-) FORMUL 6 HOH *194(H2 O) HELIX 1 AA1 ASP A 52 GLY A 64 1 13 HELIX 2 AA2 THR A 73 ARG A 77 5 5 HELIX 3 AA3 LEU A 107 GLN A 113 5 7 HELIX 4 AA4 ALA A 138 MET A 143 5 6 HELIX 5 AA5 ASN A 163 ASP A 171 1 9 HELIX 6 AA6 ASP A 171 PHE A 182 1 12 HELIX 7 AA7 GLY A 184 ALA A 189 1 6 HELIX 8 AA8 HIS A 202 SER A 210 1 9 HELIX 9 AA9 ARG A 217 THR A 222 1 6 HELIX 10 AB1 SER A 260 LEU A 275 1 16 HELIX 11 AB2 ASN A 302 GLN A 315 1 14 HELIX 12 AB3 THR A 327 ASN A 337 1 11 HELIX 13 AB4 GLY A 346 LEU A 355 5 10 HELIX 14 AB5 ASN A 370 TYR A 374 5 5 HELIX 15 AB6 THR A 375 MET A 382 1 8 HELIX 16 AB7 MET A 397 GLU A 399 5 3 HELIX 17 AB8 ALA A 420 SER A 428 1 9 HELIX 18 AB9 ASN A 439 TYR A 447 1 9 HELIX 19 AC1 ASP A 453 VAL A 464 1 12 HELIX 20 AC2 PRO A 509 LEU A 515 5 7 SHEET 1 AA1 7 VAL A 102 LEU A 104 0 SHEET 2 AA1 7 HIS A 66 THR A 70 1 N MET A 67 O VAL A 102 SHEET 3 AA1 7 ILE A 78 LYS A 82 -1 O ARG A 80 N VAL A 68 SHEET 4 AA1 7 ALA A 232 VAL A 234 -1 O ALA A 232 N PHE A 81 SHEET 5 AA1 7 ALA A 153 ALA A 156 1 N ALA A 153 O PHE A 233 SHEET 6 AA1 7 ARG A 190 PHE A 193 1 O PHE A 192 N LEU A 154 SHEET 7 AA1 7 LEU A 215 LEU A 216 1 O LEU A 215 N PHE A 193 SHEET 1 AA2 5 PHE A 132 PRO A 136 0 SHEET 2 AA2 5 GLU A 92 HIS A 97 1 N HIS A 97 O LEU A 135 SHEET 3 AA2 5 LEU A 84 SER A 87 -1 N CYS A 85 O ILE A 94 SHEET 4 AA2 5 LEU A 226 PHE A 229 -1 O PHE A 229 N LEU A 84 SHEET 5 AA2 5 VAL A 147 VAL A 149 1 N VAL A 147 O LEU A 226 SHEET 1 AA3 2 LEU A 117 ASP A 118 0 SHEET 2 AA3 2 TYR A 129 PHE A 130 -1 O PHE A 130 N LEU A 117 SHEET 1 AA4 2 TYR A 243 GLN A 244 0 SHEET 2 AA4 2 GLY A 252 PRO A 253 -1 O GLY A 252 N GLN A 244 SHEET 1 AA5 5 LYS A 317 VAL A 321 0 SHEET 2 AA5 5 TYR A 288 PHE A 292 1 N VAL A 291 O VAL A 319 SHEET 3 AA5 5 MET A 340 MET A 344 1 O VAL A 342 N PHE A 292 SHEET 4 AA5 5 THR A 360 PHE A 365 1 O VAL A 362 N LEU A 341 SHEET 5 AA5 5 GLN A 389 ARG A 394 1 O VAL A 391 N VAL A 361 SHEET 1 AA6 2 THR A 401 VAL A 402 0 SHEET 2 AA6 2 ASP A 449 THR A 450 -1 O ASP A 449 N VAL A 402 SHEET 1 AA7 3 ARG A 486 HIS A 495 0 SHEET 2 AA7 3 GLU A 499 GLN A 507 -1 O GLN A 507 N ARG A 486 SHEET 3 AA7 3 ASN A 543 PHE A 546 -1 O PHE A 546 N LEU A 502 SHEET 1 AA8 4 TYR A 537 LEU A 539 0 SHEET 2 AA8 4 VAL A 520 GLU A 528 -1 N TYR A 522 O LEU A 539 SHEET 3 AA8 4 THR A 555 PHE A 564 -1 O ILE A 563 N LYS A 521 SHEET 4 AA8 4 LEU A 568 LEU A 569 -1 O LEU A 568 N PHE A 564 SHEET 1 AA9 4 TYR A 537 LEU A 539 0 SHEET 2 AA9 4 VAL A 520 GLU A 528 -1 N TYR A 522 O LEU A 539 SHEET 3 AA9 4 THR A 555 PHE A 564 -1 O ILE A 563 N LYS A 521 SHEET 4 AA9 4 LEU A 576 ASN A 579 -1 O CYS A 578 N TYR A 556 SSBOND 1 CYS A 69 CYS A 79 1555 1555 2.04 SSBOND 2 CYS A 85 CYS A 228 1555 1555 2.07 SSBOND 3 CYS A 436 CYS A 437 1555 1555 2.04 SSBOND 4 CYS A 490 CYS A 578 1555 1555 2.03 LINK ND2 ASN A 99 C1 NAG A 602 1555 1555 1.44 CISPEP 1 LEU A 104 PRO A 105 0 6.17 CISPEP 2 GLN A 113 PRO A 114 0 3.06 CISPEP 3 CYS A 436 CYS A 437 0 -5.60 CRYST1 129.840 129.840 81.560 90.00 90.00 90.00 P 4 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007702 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007702 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012261 0.00000